SiS-101-ADO2

N/A

Report date: 2025/05/08 11:40:46
NME

Base Information

Drug NameSiS-101-ADO2
Drug Alias NameSIS-101-ADOSiS-101-ADO2
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionChloride channel protein 7 inhibitors
TargetsChloride channel protein 7
Therapy Area/IndicationsOsteopetrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of L'Aquila
China Registration ClassN/A

Develop Information

Active CompaniesSiSaf Ltd
Inactive CompaniesN/A
Active IndicationsOsteopetrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A